Trial Profile
Phase I/II Study of Preoperative Gemcitabine in Combination With Oral Hydroxychloroquine (GcHc) in Subjects With High Risk Stage IIb or III Adenocarcinoma of the Pancreas
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Hydroxychloroquine (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions; Biomarker
- 25 Jan 2020 Results presented at the 2020 Gastrointestinal Cancers Symposium
- 16 Apr 2019 Status changed from active, no longer recruiting to completed.
- 06 Jul 2017 Planned End Date changed from 1 Mar 2016 to 1 Mar 2018.